Literature DB >> 9642033

Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice.

R Kaminski1, M Kozicka, J Parada-turska, M Dziki, Z Kleinrok, W A Turski, S J Czuczwar.   

Abstract

Prostaglandins and their inhibitors may affect convulsive phenomena. Thus, the aim of this study was to examine possible interactions between non-steroidal anti-inflammatory drugs and two conventional antiepileptic drugs in terms of their anticonvulsive activity and side-effects. Also, the plasma levels of antiepileptics were measured in order to delineate possible pharmacokinetic interactions. The following non-steroidal anti-inflammatory drugs (NSAIDs) were studied: acetylsalicylic acid, ibuprofen, indomethacin, metamizole, paracetamol and piroxicam. None of these drugs affected the threshold for electroconvulsions. However, all NSAIDs studied enhanced the protective activity of valproate magnesium against maximal electroshock-induced seizures. Only ibuprofen and piroxicam enhanced the anticonvulsive activity of diphenylhydantoin. Ibuprofen decreased the ED50 value of valproate (for the induction of motor impairment) in the rotorod test, whilst piroxicam reduced the ED50 value of valproate in rotorod and chimney tests. Diphenylhydantoin combined with either ibuprofen or piroxicam did not cause any motor impairment in these tests. The total plasma level of valproate and free plasma level of diphenylhydantoin remained unchanged in the presence of all studied NSAIDs. These data demonstrate that NSAIDs could enhance the protective activity of antiepileptics. However, in case of valproate it may be associated with the severe side effects. Copyright 1998 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642033     DOI: 10.1006/phrs.1998.0309

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  Acetaminophen inhibits status epilepticus in cultured hippocampal neurons.

Authors:  Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Neuroreport       Date:  2011-01-05       Impact factor: 1.837

Review 2.  The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism.

Authors:  Basil Rigas; George J Tsioulias
Journal:  J Pharmacol Exp Ther       Date:  2015-04       Impact factor: 4.030

3.  An overview of clinical pharmacology of Ibuprofen.

Authors:  Rabia Bushra; Nousheen Aslam
Journal:  Oman Med J       Date:  2010-07

4.  Maintenance of the Innate Seizure Threshold by Cyclooxygenase-2 is Not Influenced by the Translational Silencer, T-cell Intracellular Antigen-1.

Authors:  Yifan Gong; James A Hewett
Journal:  Neuroscience       Date:  2018-01-11       Impact factor: 3.590

5.  Screening of prototype antiseizure and anti-inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy.

Authors:  Cameron S Metcalf; Fabiola Vanegas; Tristan Underwood; Kristina Johnson; Peter J West; Misty D Smith; Karen S Wilcox
Journal:  Epilepsia Open       Date:  2021-11-03

6.  Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells.

Authors:  Barbara Bennani-Baiti; Stefan Toegel; Helmut Viernstein; Ernst Urban; Christian R Noe; Idriss M Bennani-Baiti
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 7.  Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management.

Authors:  Chitra Rawat; Samiksha Kukal; Ujjwal Ranjan Dahiya; Ritushree Kukreti
Journal:  J Neuroinflammation       Date:  2019-10-30       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.